Iksuda Therapeutics develops next-generation antibody-drug conjugate (ADC) therapies to target cancers that are difficult to treat, or resistant to current treatments, without damaging healthy cells.

EADaily, July 2nd, 2026. For Ukraine, air conditioning has long become a familiar household appliance. In Europe, even ...

Circle, the issuer of the USDC stablecoin, has published new insights highlighting how programmable money is reshaping enterprise payments. The company’s ...

EADaily, July 2nd, 2026. The wars of the future will be fought not for oil, but for water. This is no longer just a forecast ...

LMAX Group and Standard Chartered (LON: STAN) have executed the first live trades under a digital asset prime brokerage model. The pilot transactions involved ...

Anders Lee signed a three-year, $16.2 million contract with the Utah Mammoth on Wednesday. It has an average annual value of ...